文献速递细菌感染、耐药与抗菌药物

抗IL-6免疫治疗期间A组链球菌机会性侵袭性感染

Opportunistic Invasive Infection by Group A Streptococcus During Anti-Interleukin-6 Immunotherapy.
PubMed 文献 · J Infect Dis · 2021-01-01

该研究从接受IL-6生物抑制剂治疗的患者血液中分离出M4型A组链球菌,并在人血和鼠菌血症模型中证实IL-1或IL-6抑制促进该菌株生长,而高侵袭性M1T1菌株不受IL-6影响,提示IL-6信号缺陷是侵袭性GAS感染的危险因素。

要点

  • 接受IL-6抑制剂治疗的患者发生侵袭性GAS感染时,应考虑免疫缺陷相关风险。
  • M4型GAS在IL-6抑制条件下生长增强,而高侵袭性M1T1菌株不受影响。
  • IL-6信号缺陷可能是侵袭性GAS感染的新危险因素。

核心结论

  • IL-6信号缺陷是侵袭性A组链球菌感染的危险因素。

研究设计与样本

  • 基于一例接受IL-6生物抑制剂治疗患者的自然实验,结合人血和鼠菌血症模型。

主要发现

  • 从接受IL-6抑制剂的患者血液中回收了M4型GAS分离株。
  • 在人血或鼠菌血症模型中,IL-1或IL-6抑制促进该M4分离株生长。
  • 高侵袭性M1T1 GAS在两种模型中均不受IL-6影响。

临床怎么用

  • 对接受IL-6抑制剂治疗的患者,应警惕侵袭性GAS感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Invasive group A Streptococcus (GAS) in immunocompetent individuals is largely linked to hypervirulent strains. Congenital immunodeficiencies and those acquired from chronic disease or immunosuppressant drugs also increase risk of severe illness. We recovered GAS from the blood of a patient receiving a biologic inhibitor of interleukin 6 (IL-6). Growth of this serotype M4 isolate in human blood or a murine bacteremia model was promoted by interleukin 1 or IL-6 inhibition. Hyperinvasive M1T1 GAS was unaffected by IL-6 in both models. These findings based on a natural experiment introduce IL-6 signaling deficiencies as a risk factor for invasive GAS.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wilde S, Olivares KL, Nizet V, et al. Opportunistic Invasive Infection by Group A Streptococcus During Anti-Interleukin-6 Immunotherapy. J Infect Dis. 2021. PMID: 32808035. doi:10.1093/infdis/jiaa511

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。